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ABSTRACT 
 
Notch signalling is essential to maintain skeletal muscle stem cells in quiescence. The 
precise roles of the different Notch receptors are, however, incompletely defined. Here 
we demonstrate a role for Notch3 in the self-renewal of muscle stem cells. We found that 
Notch3 is active in quiescent C2C12 reserve cells, and Notch3 over-expression and 
knockdown studies in C2C12 and primary satellite cells reveal a role in self-renewal. The 
Notch ligand Delta-like 4 (Dll4) is expressed by newly formed myotubes and interaction 
with this ligand is sufficient to maintain Notch3 activity in quiescent C2C12 reserve cells 
to prevent activation and progression into the cell cycle. Thus our data suggest a model 
whereby during regeneration, expression of Dll4 by nascent muscle fibres triggers 
Notch3 signalling in associated muscle stem cells to recruit them to quiescence, thereby 
renewing the stem cell pool.
INTRODUCTION 
 
Satellite cells (SCs) are resident skeletal muscle stem cells for postnatal muscle 
growth, maintenance, and repair/regeneration [1-3]. Notch signalling has been implicated 
in maintaining SC quiescence [4,5] as well as promoting SC proliferation during 
regeneration [6,7]. Notch receptor activation is initiated by interaction with a DSL (for 
Delta-Serrate- Lag) ligand that promotes a series of conformational and proteolytic 
events that release the active Notch intracellular domain (ICD) which translocates to the 
nucleus and associates with the DNA-binding protein CSL (for CBF1/Su(H)/Lag-1: also 
known as RBP-J or Rpbsuh). In the absence of Notch ICD, CSL functions as a 
transcriptional repressor: binding of Notch ICD displaces associated co-repressor 
molecules and recruits a complex of co-activators, thereby acting as a switch for the 
expression of Notch-responsive genes, primarily those of the Hes and Hey families [8]. 
Although the core pathway is highly conserved, Notch signalling has a diverse (often 
conflicting) range of context-dependent biological functions probably due to the selective 
activation of a functionally heterogeneous group of downstream effectors by different 
combinations of the four Notch receptors (Notch1-4) and five DSL ligands (Delta-like 
(Dll) 1, 3 and 4 and Jagged 1 and 2) identified in mammals. For example, Notch1 has 
been reported to mediate SC transition into quiescence in vivo [9], and also myoblast 
proliferation in vitro [6]. Notch3 is expressed by quiescent SCs [10, 11] and Notch3 
mutant mice regenerate more muscle and SCs after repeated injuries [12]. Although, 
these studies implicate Notch3 in SC homeostasis, the underlying cellular mechanism(s) 
are unclear.  
MATERIALS AND METHODS 
Primary Cell Culture 
Mice were bred and experimental procedures passed by the Ethical Review 
Process Committee of King's College London were carried out under the provisions of 
the Animals (Scientific Procedures) Act 1986. Freshly isolated myofibers [13, 14] 
were mildly digested with 0.125% trypsin–EDTA for 10 min at 37 °C, and the released 
satellite cells were plated on Matrigel in 75 cm2 flasks or 6-well plates and maintained at 
low density for several days in DMEM supplemented with 20% FBS, 1% chicken 
embryo extract, 4 mM L-glutamine and 100 IU/ml penicillin/100 µg/ml streptomycin. 
Cells were then trypsinised and seeded in Lab-Tek 8-well chamber slides for transfection. 
 
C2C12 maintenance, differentiation and reserve cell isolation  
C2C12 myoblasts (European Collection of Cell Cultures) were maintained in 
growth medium supplemented with 20% foetal calf serum (PAA Laboratories) and 
induced to differentiate in medium containing 5% horse serum (PAA Laboratories) as 
described previously [13]. After 5 days of differentiation, cultures were separated into 
myotube and reserve fractions by partial trypsinisation. Briefly, cultures were rinsed with 
PBS and then incubated in 0.01% trypsin (Sigma) in PBS until the myotubes were seen to 
detach from the substrate. The released myotubes were retained and the adherent cells 
rinsed again with PBS and then subjected to a series of 3, 1 min incubations in 0.01% 
trypsin (with intervening PBS washes) to remove residual myoblasts and myocytes. The 
remaining reserve cells were either processed to obtain RNA or protein, or re-plated for 
activation in growth medium or in co-culture. The successful enrichment of the myotube 
and reserve cell fractions was confirmed by RT-PCR (Fig. S1). 
 
Western Blotting 
15g of total protein (extracted by cell lysis in RIPA buffer containing protease 
inhibitor cocktail (Pierce)) were separated on 4-12% polyacrylamide gradient gels (In 
Vitrogen) and transferred onto nitrocellulose membrane (Hybond-ECL: GE Healthcare). 
Membranes were probed with goat polyclonal anti-Notch 1 (M20, 1:200), anti-Notch3 
(M20, 1:200), anti-Jagged 1 (C20, 1:200), anti-Dll1 (T-20, 1:100), anti-Dll4 (C20, 1:100) 
(all from Santa Cruz Biotechnology), rat monoclonal anti-activated Notch1 (bTAN 20, 
1:50, DSHB), mouse monoclonal anti-cyclin A (C4710, 1:1000) and anti--tubulin 
(T9026, 1:2500) (both from Sigma). Primary antibodies were detected using appropriate 
species-specific, HRP-conjugated secondary antibodies (DakoCytomation) in conjunction 
with an ECL chemiluminescent detection kit (Pierce). An intermediate biotinylated 
secondary antibody followed by streptavidin-HRP (1:4000, Invitrogen) was used to 
detect Notch3. 
 
Reverse Transcription and PCR (RT-PCR) 
Total RNA was extracted using Trizol (Invitrogen) according to manufacturer’s 
instructions. RT-PCRs were carried out using a One-Step kit (Qiagen) with the following 
murine gene-specific primer pairs (all 5’→3’): Notch1 forward 
TGGACGCCGCTGTGAGTCA, Notch1 reverse TGGGCCCGAGATGCATGTA (202bp 
product, 28 cycles); Notch3 forward CCTGGATGCTGGGGCGGACAC, Notch3 reverse 
CGGCATGGCTGGCGATGAGCT (218bp product, 28 cycles); MyoD forward 
CGGCGGCAGAATGGCTACGA, MyoD reverse GAGGGGCGGCGTCGGGAGAC 
(253bp product, 25 cycles); HPRT forward GCTGGTGAAAAGGACCTCTC, HPRT 
Reverse CACAGGACTAGAACACCTGC (249bp product, 25 cycles). Additional RT-
PCRs presented in Fig. S1 were carried out using: CD34 forward 
TGGAATCCGAGAAGTGAGGT, CD34 reverse ACCCAGCCTTTCTCCTGTAG 
(442bp product, 28 cycles); myogenin forward TTGCTCAGCTCCCTCAACCA, 
myogenin reverse TGGGCTGGGTGTTAGCCTTA (445bp product, 28 cycles).  
 
Retroviruses 
An eGFP-mouse Notch1 ICD fusion cDNA (EGFP-NIC [15]) was cloned into 
pMSCV-puro (Clontech); cDNA encoding the murine Notch3 intracellular domain fused 
to a carboxy-terminal HA tag (N3IC-HA [16]) was cloned into pMSCV-IRES-GFP, a 
modified version of pMSCV-puro [19]. Retroviruses were packaged in HEK 293T cells 
using standard methods. 
 
Retroviral Infection and Immunostaining of Satellite Cells on Isolated Myofibres 
Myofibres were isolated from extensor digitorum longus muscles of 12 week-old 
C57Bl/10 mice as described by Rosenblatt et al. [20]. Freshly isolated myofibre 
preparations were retrovirally infected and then maintained in suspension for 72 h in 
DMEM supplemented with 10% horse serum and 0.5% chick embryo extract (PAA 
Laboratories) as described previously [19]. 
Fibres were fixed for 20 min in 4% paraformaldehyde in PBS, permeabilised with 
0.1% Triton X-100 for 10 min and then incubated for at least 30 minutes in 20% (v/v) 
normal goat serum in PBS to block non-specific antibody binding, all at room 
temperature. Rabbit polyclonal anti-GFP (1:400, Molecular Probes) and either mouse 
monoclonal anti-Pax7 (1:50; DSHB), anti-MyoD (clone 5.8a, 1:50; DakoCytomation) or 
anti-Dll4 (C20, 1:50; Santa Cruz Biotechnology) were applied for 16 h at 4°C. Fibres 
were incubated for 1 h at room temperature in flurochrome-conjugated species-specific 
secondary antibodies (Molecular Probes) to visualise primary antibody binding. All 
antibodies were diluted in 6% horse serum in PBS and the fibres were mounted in 
DakoCytomation Faramount fluorescent mounting medium containing 100ng/ml 4,6-
diamidino-2-phenylindole (DAPI) as a nuclear counterstain. 
 
Retroviral Infection and Immunostaining of C2C12 Myoblasts 
Proliferating C2C12 myoblasts were infected with retroviruses as described previously 
[19]. After 48 hours, infected GFP+ve cells were sorted using a FACS DiVa flow 
cytometer and cell sorter (Becton Dickinson) and expression of the relevant Notch ICD 
confirmed by Western blotting. Infected myoblasts were seeded into LAB-TEK® 
Permanox™ 8-well chamber slides (Nunc) in growth medium and 24 h later, pulsed for 1 
hour with 40M BrdU. Cultures were fixed, permeabilised and immunostained with 
either mouse monoclonal anti-MyoD antibody (see above) or rat monoclonal anti-BrdU 
antibody (clone BU1/75, 1:500, Abcam) as described previously [13]. Primary antibody 
binding was detected using species-specific flurochrome-conjugated seconday antibodies 
(Molecular Probes) before mounting in DakoCytomation Faramount fluorescent 
mounting medium containing 100ng/ml (DAPI). 
 
shRNA knockdown of Notch3 and Dll4 
Knockdown of Notch3 and Dll4 expression was achieved using a SureSilencing™ 
shRNA/GFP plasmid (SABiosciences) encoding the shRNA 
TCCCAGCGAGCATCCTTATTT and  AACAGTGGGCCAAAGGGTTAT, 
respectively. Effective knockdown was confirmed by Western blot analysis of Notch3 
and Dll4 expression in transiently transfected C2C12 cultures (Fig. S2 A and B). 
Proliferating myoblasts were co-transfected with pCI-neo and either the knockdown 
plasmid or the supplied control plasmid consisting of an encoding an irrelevant, 
scrambled shRNA sequence, using Lipofectamine 2000 (Invitrogen) and selected with G-
418. GFP expression was confirmed by flow cytometry before seeding in LAB-TEK® 
Permanox™ 8-well chamber slides for differentiation. After 5 days in differentiation 
medium, cultures were fixed, permeabilised and immunostained with mouse monoclonal 
anti-skeletal muscle myosin (clone MF20, 1:50, DSHB) and rabbit polyclonal anti-GFP 
antibodies (A11622, 1:400, Molecular Probes), followed by appropriate species-specific 
fluorochrome-conjugated secondary antibodies, as above. 
 
Co-culture of Reserve Cells With DSL Ligand-Expressing 3T3 Cells 
Full-length murine Dll4 and Dll1 [21] and Jagged 1 [22] cDNAs were each cloned 
into pCI-neo (Promega) and transfected into 3T3 fibroblasts using Lipofectamine 2000. 
Transfected cells were selected by using G-418 and expression of the relevant ligand 
confirmed by RT-PCR and Western blotting (no endogenous expression of Dll1, Dll4 or 
Jagged 1 was detected). 
For co-culture, 3T3 fibroblasts were grown to confluence in LAB-TEK® Permanox™ 
8-well chamber slides (for analysis by immunofluorescent staining) or 10cm-diameter 
dishes (for Western blot analysis) prior to the addition of reserve cells. C2C12 myoblasts 
were transfected with pmaxFP-Green-N (Amaxa) using Lipofectamine 2000 and 
transfectants selected with G-418. Cultures of GFP+ve myoblasts were allowed to 
differentiate for 5 days, the reserve cells were isolated and then applied to the fibroblast 
monolayers (4000 reserve cells/well; 2 x 105 reserve cells/dish) an approximate ratio of 
1:3 (reserve cell: fibroblast). Co-cultures were maintained for 24 h in growth medium 
prior to analysis. Co-cultures maintained in chamber slides were pulsed with BrdU for 1 
h and analysed by immunostaining; co-cultures in dishes were used to produce protein 
and RNA for Western blotting and RT-PCR. 
 
 
RESULTS 
We initially investigated the role of Notch3 by use of the C2C12 reserve cell model 
[18] to model cell fates adopted during muscle regeneration. In this model, when 
stimulated to differentiate, most cells form multinucleated myotubes, but a fraction of 
cells become quiescent reserve cells (Fig. 1A). Reserve cells resemble quiescent SCs in 
that they express Pax7 and CD34 but not MyoD, bind Lysenin, and can be reactivated to 
again proliferate [17-19]. Evaluating the levels of active Notch1 and Notch3 during the 
differentiation time course by Western blot (Fig. 1B), we found that active Notch1 is 
present throughout, whilst Notch3 is up-regulated 1 day after differentiation is induced, 
reaching maximum levels after 3 days. Notch3 up-regulation was coincident with the 
appearance of myotubes. After 5 days, myotube and reserve cell fractions were separated 
for Western blot analysis, which revealed that active Notch1 was mainly in myotubes, 
whereas active Notch3 was exclusively in reserve cells, consistent with Notch3 
expression in quiescent SCs [10,11].  
 
To examine the role of Notch3, we activated Notch signalling through Notch3 and 
Notch1 by retroviral-mediated expression of a constitutively active Notch3-intracellular 
domain (Notch3-ICD) or a Notch1-ICD (for comparison) in SCs on isolated murine 
muscle fibres (Fig. 2A-C); GFP co-expression was used for identifying transduced cells. 
72 hours after infection we found that, whereas expression of Notch1 ICD had no 
significant effect on proliferation, SC expressing active Notch3 ICD gave rise to 
significantly fewer progeny compared with controls infected with parental retrovirus, 
whereas expression of Notch1 ICD had no significant effect on proliferation. In the 
control preparations, ~50% of GFP+ve cells were Pax7+ve (stem cell fate) and ~75% 
expressed MyoD (progenitor fate). In contrast, ~ 90% of cells expressing Notch1-ICD or 
Notch3-ICD were Pax7+ve. Notch1-ICD reduced the MyoD+ve fraction, whilst Notch3-
ICD nearly abolished this fraction. Similar results were found using C2C12 myoblasts 
(Fig. 2D): both Notch1-ICD and Notch3-ICDs reduced the MyoD+ve fraction, whilst 
only Notch3-ICD reduced their proliferation rate, as assessed measuring by BrdU 
incorporation. There are conflicting reports on the effect of Notch1 activity on muscle 
stem cell behaviour: whilst overexpression of exogenous Notch1-ICD has been shown to 
promote proliferation [6,7], SC-specific genetic gain-of-function studies suggest that 
Notch1 activity directly inhibits cell division [9]. We found that whilst transfection with 
Notch1-ICD significantly inhibited myogenic progression in terms of MyoD expression, 
there was no effect on proliferation rate, possibly because of a maximal response to 
endogenous Notch1 activity. In contrast, Notch3 induced a MyoD-ve, non-proliferative 
‘quiescent’ state in SC, C2C12 and primary myoblasts. 
Conversely, we asked whether reducing Notch3 would reduce the number of 
myoblasts entering quiescence? We used shRNA (with GFP co-expression) to 
knockdown Notch3, just prior to initiating differentiation in C2C12 myoblasts (Fig. 2E) 
and primary myoblasts (Fig. S2C-D); efficient reduction of Notch3 expression was 
achieved (Fig. S2A). Notch3 knockdown resulted in more myotubes (expressing skeletal 
muscle myosin, SkMM) (Fig. 2E, Fig. S2C), more MyoD+ve and fewer Pax7+ve cells 
(Fig. S2D) compared with the scrambled shRNA control. The proportion of GFP+ve 
SkMM-ve cells (i.e. reserve cells) was significantly lowered by Notch3 knockdown, 
relative to controls (Fig 2E, Fig. S2C), whereas N3-ICD overexpressing primary cultures 
contained less myotubes compared to controls (Fig. S2C).  Significantly, Dll4 
knockdown shRNA also resulted in more myotubes (Fig. 2F) and fewer undifferentiated 
cells (Fig. 2F) compared with the scrambled shRNA control.  
We next examined the activities of Notch1 and Notch3 as reserve cells re-entered the 
cell cycle. Isolated reserve cells were stimulated with growth medium and pulse-labelled 
with BrdU at selected time points. Almost all cells entered S-phase within 12-24 hours 
(Fig. 3A). Re-entering the cell cycle was preceded by down-regulation of Notch3 mRNA 
and active Notch3 protein. In contrast, Notch1 mRNA and active Notch1 protein 
displayed concomitant up-regulation with MyoD mRNA and CyclinA (Fig. 3B,C). 
Proliferating myoblasts expressed Notch ligands Dll1, Jagged1 and barely detectable 
levels of Dll4. Expression of all three increased during differentiation but with different 
distributions: Dll1 expression was higher in myotubes than in reserve cells; Dll4 was 
restricted to myotubes, and Jagged 1 to reserve cells. Dll3 was not detected and Jagged2 
showed the same pattern as Jagged1.The findings suggested that the presence of Dll1 or 
Dll4 on new myotubes, or Dll1 or Jagged1 on reserve cells, could be responsible for 
activating Notch3 in adjacent cells.  
To test their roles individually, reserve cells from differentiated GFP+ve C2C12 
cultures were isolated and co-cultured in growth medium with wildtype NIH3T3 cells 
(control) or NIH3T3 cells expressing Dll1, Dll4 or Jagged1, to activate Notch signalling. 
When cultured alone or with control NIH3T3 cells, approximately 90% of the reserve 
cells had entered the cell cycle and incorporated BrdU after 24 hours. Co-culture with 
NIH3T3 cells expressing Dll1 or Jagged1 had no effect on reserve cell activation and 
proliferation (Fig 4A). In marked contrast, co-culture with Dll4-expressing cells 
significantly inhibited reserve cell activation and proliferation. After 24 hours in growth 
medium, only ̴ 20% had entered the cell cycle and incorporated BrdU. The remaining ̴ 
80% had not incorporated BrDU and were still quiescent, as determined by lysenin 
binding (Fig. 4B).  Importantly, reserve cells co-cultured with Dll4-expressing NIH3T3 
cells contained the active form of Notch3, but the inactive form of Notch1 (Fig. 4C), as 
opposed to the presence of the active forms of both Notch3 and Notch1 under co-culture 
with control NIH3T3 or those expressing Dll1 or Jagged1 (Fig. 4C). RT-qPCR data 
further confirmed that exposure of reserve cells to Dll4 maintained Notch3 expression 
and prevented up-regulation of Notch1 and MyoD (Fig 4D). In freshly isolated murine 
myofibres, immunolabelling revealed that quiescent satellite cells were exposed to Dll4 
until at least 24 hours of culture, but that Dll4 expression was lost by 48 hours (Fig. 4E). 
 
DISCUSSION 
Different combinations of Notch receptor and ligand are known to result in different 
outcomes, even within the same biological system [21, 23]. Here we defined the paired 
actions of Notch3 in stem/progenitor cells and Dll4 in muscle fibres to establish and 
maintain a quiescent stem cell phenotype. It is interesting to note that Bi et al. [24] 
reported that Notch1 activation in myofibres results in the upregulation of Dll4 
expression which could contribute to the sequestration and maintenance of the satellite 
cell population during regeneration.  Our results help explain the Notch3 mutant muscle 
regeneration phenotype, in which SCs do not adopt self-renew effectively and excessive 
muscle regeneration occurs [12]. Notch1 was recently been shown to instruct 
proliferative SCs to transition into quiescence in juvenile mice [9]. It is possible that 
Notch1 has a unique property during the juvenile stage, or that inactivation of Notch1 
also inadvertently reduce or inhibit Notch3 activity. However, these data are consistent 
with the hypothesis that myotubes provide the signal to impose SC quiescence. Such a 
feedback mechanism by which differentiated cells are responsible for the recruitment and 
maintenance of a stem cell compartment may explain how, following widespread damage 
muscle regeneration restores both functional tissue and an equivalent stem cell 
compartment.   
 
CONCLUSION 
Our work shows that the expression of Dll4 in myotubes activates Notch3 in adjacent 
myoblasts to signal them to stop proliferating and return to quiescence. By thus 
controlling muscle stem cell self-renewal, the Dll4/Notch3 axis restores the stem cell 
pool after muscle repair/regeneration to be able to respond to further needs of 
homeostasis, hypertrophy or repair.  
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FIGURE LEGENDS 
Fig. 1: Active Notch 3 is expressed by quiescent myogenic cells. (A) Schematic 
depicting the alternate cell fates adopted during myogenic differentiation in vitro. When 
cultures of proliferating myoblasts (Mb) are induced to differentiate, most fuse together 
to form differentiated, multinucleated myotubes (Mt). In contrast, a minority become 
reserve cells (RC), adopting a phenotype equivalent to that of a quiescent satellite cell. 
After 5 days, Mt and RC fractions can be separated by partial trypsination. (B) Western 
blot analysis of Notch receptor and ligand expression in differentiating C2C12 cultures 
and in separated Mt and RC fractions, prepared after 5 days of differentiation (U = 
unseparated cultures). The two bands on blots probed with antibodies raised against the 
Notch receptor intracellular domains correspond to the membrane-bound inactive form 
(upper band) and to the active form (lower band) released by proteolytic cleavage [8].   
-Tubulin was used as a loading control. 
 
Fig. 2: Notch 3 ICD promotes exit from the cell cycle. (A, B and C) Satellite cells on 
freshly isolated muscle fibres were transduced with retrovirus encoding Notch1 ICD (N1 
ICD) or Notch3 ICD (N3 ICD) or an empty control vector (Cont), with an IRES-eGFP 
marking transduced cells. Immunostaining for Pax7 and GFP 24 h after transduction 
showed that approximately 50% of satellite cells had been infected. (A) The number of 
GFP+ve cells per fibre (n = 10 fibres per group) and the proportion of GFP+ve cells 
expressing either Pax7 or MyoD (n = 150-250 GFP+ve cells) were determined after 72 h. 
Data are mean ± SEM, compared using Student’s t-test. (B) Representative clusters of 
satellite cell progeny, immunolabelled for Pax7 (red) and GFP (green). Arrowheads 
indicate Pax7-ve/GFP+ve cells. (C) Representative clusters immunolabelled for MyoD 
(red) and GFP (green), arrowheads indicate MyoD-ve/GFP+ve cells. GFP produced as a 
fusion with Notch1 ICD localised to the nucleus; GFP in control and Notch3 ICD-
expressing cells was produced from an IRES and therefore is cytoplasmic. Preparations 
were counterstained with DAPI to reveal all nuclei: scale bar represents 10M. (D) 
Effects of Notch3 and Notch 1 ICD on C2C12 myoblasts. Proliferating myoblasts 
transduced with the same retroviruses were pulsed for 1 h with BrdU and 
immunolabelled for MyoD and BrdU. Representative untransfected (C212) and Notch3 
ICD-expressing cultures are shown, positive cells show red nuclear staining. Data are the 
mean ± SEM from 3 cultures (100-200 cells per culture), statistically compared using 
Student’s t-test. Scale bar equals 50M. (E and F) shRNA knockdown of Notch3 (E) or 
Dll4 (F). C2C12 myoblasts transfected with an shRNA (N3 or Dll4 knockdown) or an 
irrelevant, scrambled sequence (Cont) were allowed to differentiate for 5 days. Cultures 
were stained for skeletal muscle myosin (SkMM, red), a marker of differentiation and 
counterstained with DAPI to reveal all nuclei (blue) to determine the proportion of nuclei 
in differentiated cells. Immunolabelling of replicate cultures for GFP was used to 
determine the proportion of undifferentiated cells expressing the shRNA plasmids. Data 
are the mean ± SEM of 3 cultures (200 nuclei per culture), compared by Student’s t-test. 
Scale bar equals 100M. 
 
Fig. 3: During reserve cell activation, Notch3 signalling is suppressed while Notch1 
signalling is activated. (A) Cultures of C2C12 reserve cells were transferred to growth 
medium and analysed at the shown time points following a 1 h pulse with BrdU. 
Representative cultures immunolabelled to reveal BrdU (red) and counterstained with 
DAPI (blue) to identify all nuclei are shown. Data are the mean ± SEM of 3 cultures 
(100-200 cells per culture). Scale bar equals 50M. (B) RT-PCR analysis of Notch3, 
Notch1 and MyoD expression during reserve cell reactivation, with HPRT as a control 
(C) Western blot analysis of cultures harvested at the same time points. Active 
corresponds to the active form of Notch3, generated by cleavage at the membrane to 
generate N3-ICD; Inactive indicates the higher molecular mass membrane-bound form; 
and Unprocessed refers the receptor prior to S1 cleavage [8]. Antibody specific for the 
active form of Notch1 was used. 
 
Fig. 4: Dll4 signals through Notch3 to maintain myogenic quiescence. (A-D) GFP+ve 
reserve cells were maintained in growth medium for 24 h either alone (RC), or in co-
culture with wildtype NIH3T3 fibroblasts (Cont) or NIH3T3 cells expressing Dll1, Dll4 
or Jagged 1 (Jag1). (A) Cultures pulsed with BrdU for 1 h (23-24 h) were 
immunolabelled for GFP (green) to identify reserve cells and BrdU incorporation (red), 
and counterstained with DAPI to reveal all nuclei, and the proportion of 
GFP+ve/BrdU+ve cells determined. Representative images of reserve cells co-cultured 
with wildtype NIH3T3 cells (Cont) and NIH3T3 cells expressing Dll4 only are shown. 
Arrows indicate BrdU-ve reserve cells; arrowheads indicate BrdU+ve reserve cells. (B) 
Replicate co-cultures were incubated with lysenin, a marker of quiescence [17] and the 
proportion of GFP+ve cells labelled with lysenin determined. Representative images of 
reserve cells co-cultured with control (Cont) and Dll4+ve NIH3T3 cells only are shown, 
immunolabelled for GFP (green) and lysenin binding (red). The arrow indicates a 
lysenin+ve reserve cell in co-culture with control NIH3T3 cells: arrowheads indicate 
lysenin-ve reserve cells in co-culture with Dll4+ve NIH3T3 cells. All data are the mean 
of 3 cultures ± SEM (200 GFP+ve cells per culture), compared using Student’s t-test. 
Scale bar equals 20M. (C) Western blot and (D) RT-qPCR analysis of Notch1 and 
Notch3 expression in NIH3T3 cells alone (3T3), reserve cells cultured alone (RC) and in 
reserve cells co-cultured with wildtype NIH3T3 cells (3T3) or with NIH3T3 fibroblasts 
expressing either Dll1, Dll4 or Jagged1 (Jag1). (E) Single muscle fibres were isolated and 
grown in culture for 48 h. At least 30 fibres were analysed at 0 h (T0), 24 h (T24) or 48 h 
(T48) in culture. Cells labelled with Pax7 (green, arrows), Dll4 (red, arrows) and DAPI 
(blue) can be observed on isolated muscle fibres at 0 h (T0) and 24 h (T24) however Dll4 
(red, arrowhead) was not detectable in fibres cultured for 48 h (T48). Scale bar equals 
20M. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
  
 
  
 
